harvey-d-white documents

Is Heparin of Value in the Management of Acute Myocardial Infarction?
Documents Is Heparin of Value in the Management of Acute Myocardial Infarction?
Thrombin Hypothesis: The TIMI 9B and GUSTO IIB Trials Have Successfully Disproven/Proven the Thrombin Hypothesis
Documents Thrombin Hypothesis: The TIMI 9B and GUSTO IIB Trials Have Successfully Disproven/Proven the Thrombin Hypothesis
Introduction
Documents Introduction
Relation of thrombolysis during acute myocardial infarction to left ventricular function and mortality
Documents Relation of thrombolysis during acute myocardial infarction to left ventricular function and mortality
Comparative safety of thrombolytic agents
Documents Comparative safety of thrombolytic agents
Lifting the smoke-screen: The enigma of better outcome in smokers after myocardial infarction
Documents Lifting the smoke-screen: The enigma of better outcome in smokers after myocardial infarction
“Rescue” thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction
Documents “Rescue” thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction
Unmet Therapeutic Needs in the Management of Acute Ischemia
Documents Unmet Therapeutic Needs in the Management of Acute Ischemia
Direct thrombin inhibition and thrombolytic therapy: rationale for the hirulog and early reperfusion/occlusion (HERO-2) trial
Documents Direct thrombin inhibition and thrombolytic therapy: rationale for the hirulog and early reperfusion/occlusion (HERO-2) trial
Antianginal efficacy of perhexiline maleate in patients unresponsive to β adrenoreceptor blockade
Documents Antianginal efficacy of perhexiline maleate in patients unresponsive to β adrenoreceptor blockade
Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease
Documents Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease
Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure
Documents Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure
Optimal treatment of patients with acute coronary syndromes and non–ST-elevation myocardial infarction
Documents Optimal treatment of patients with acute coronary syndromes and non–ST-elevation myocardial infarction
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effects of antiplatelet therapy
Documents Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: Effects of antiplatelet therapy
Heart, Lung and Circulation: Flagship or Millstone?
Documents Heart, Lung and Circulation: Flagship or Millstone?
Use of brain natriuretic peptide levels for risk assessment in non–ST-elevation acute coronary syndromes
Documents Use of brain natriuretic peptide levels for risk assessment in non–ST-elevation acute coronary syndromes
Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year
Documents Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year
Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an
Documents Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an
Reply
Documents Reply